DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Martin M, Loibl S, von Minckwitz G. et al.
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.
J Clin Oncol 2015;
33: 1045-1052
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.